Jul, 26 2023
Everolimus, a drug usually used for organ transplant recipients, has recently been making waves in the field of dermatology. It's been noted to significantly reduce the occurrence of various skin conditions, particularly in individuals with tuberous sclerosis complex. Researchers are hopeful about its potential in treating numerous other skin-related disorders. I am personally excited about this breakthrough and the promising future it holds for those suffering from skin conditions. This certainly is a major advancement in dermatology and I can't wait to see how it evolves.